. Author manuscript; available in PMC: 2014 Feb 1.

Published in final edited form as: Brain Behav Immun. 2012 Sep 23;28:16–24. doi: 10.1016/j.bbi.2012.09.004

Table 5.

Linear regression analysis for change in telomere length with change in n-6:n-3 fatty acid plasma ratio, controlling for baseline telomere length.

Effect	Estimate	95% CI	P-value
Intercept	1040	(296, 1785)	0.007
Telomere length, baseline	−0.15	(−0.27, −0.031)	0.01
n-6:n3 fatty acids, baseline	−21	(−44, 2.0)	0.07
Decrease in n6:n3 fatty acids^a	20	(4, 36)	0.02

Units: telomere length = base pairs.

Regression model with change in telomere length (4 months minus baseline) as the outcome

Decrease in n-6:n-3 PUFA ratio is calculated as baseline minus 4 months so that a positive value is a decrease in n-6:n-3 PUFA ratio.